v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net income $ 50,347 $ 36,141 $ 28,593
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 7,590 8,990 10,874
Amortization of intangibles 2,150 2,425 2,624
Provision for credit losses 7,750 5,153 3,029
Stock compensation expense 1,939 1,629 1,349
Gain (loss) on sale of securities, net 3,719 (64) 6,801
Deferred income tax (benefit) expense (470) 120 1,309
Increase in cash surrender value of bank-owned life insurance (3,608) (2,483) (1,964)
Net losses from sale and write-downs of other real estate owned and other repossessed assets 632 994 78
Net gains from mortgage banking (2,565) (1,463) (1,040)
Origination of loans held for sale (44,240) (49,845) (45,891)
Proceeds from sales of loans held for sale 41,936 49,730 44,265
Gain from sale of SBKI (3,955)    
Net loss (gain) from sale/disposal of fixed assets 14 (1,647) 19
Net change in:      
Accrued interest receivable (1,450) (898) (2,989)
Accrued interest payable 3,425 250 2,520
Other assets 4,114 3,788 (1,732)
Other liabilities (5,604) (120) (8,129)
Net cash provided by operating activities 61,724 52,700 39,716
Cash flows from investing activities:      
Proceeds from sales 99,966   152,775
Proceeds from maturities, calls and paydowns 72,289 57,985 56,273
Purchases (215,345) (131,376) (130,584)
Proceeds from maturities, calls and paydowns 2,474 152,486 2,494
Proceeds from sales of other investments 1,041 5,960 2,812
Purchases of other investments (6,319) (7,407) (944)
Purchases of bank-owned life insurance   (30,000)  
Proceeds from sale of SBKI, net of transaction cost 11,200    
Net increase in loans and leases (464,342) (469,247) (213,591)
Proceeds from sale of fixed assets 123 4,698 682
Purchases of premises and equipment (2,389) (6,405) (6,270)
Proceeds from sale of other real estate owned and other repossessed assets 2,254 3,084 1,113
Net cash used in investing activities (499,048) (420,222) (135,240)
Cash flows from financing activities:      
Net increase in deposits 466,338 418,696 190,887
Net increase (decrease) in securities sold under agreements to repurchase (1,126) (944) 303
Proceeds from borrowings 2,500 160,100 26,275
Repayment of borrowings (6,500) (166,600) (30,775)
Cash dividends paid (5,452) (5,422) (5,427)
Issuance of preferred stock of subsidiary - non-controlling interest, net of fees   113  
Redemption of subordinated debt (40,000)    
Issuance of subordinated debt, net of issuance costs 98,566    
Issuance of common stock 153 68 165
Restricted shares withheld for taxes (308) (223) (57)
Repurchases of common stock   (2,967)  
Net cash provided by financing activities 514,171 402,821 181,371
Net change in cash and cash equivalents 76,847 35,299 85,847
Cash and cash equivalents, beginning of period 387,570 352,271 266,424
Cash and cash equivalents, end of period 464,417 387,570 352,271
Supplemental disclosures of cash flow information:      
Cash paid during the period for interest 116,443 113,665 85,443
Net cash paid during the period for income taxes 12,390 8,774 9,347
Noncash investing and financing activities:      
Recognition of operating lease assets in exchange for lease liabilities 790 3,573 1,751
Acquisition of real estate through foreclosure   179 $ 272
Acquisition of other repossessed assets 3,918 4,396  
Financed sales of other repossessed assets $ 1,433 $ 1,132